Cormorant Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Cormorant Asset Management’s Portfolio AMLX Stock Details AMLX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$6.79M	Buy
2023 Q1	–	Sell
2022 Q4	$20.3M	Sell
2022 Q3	$17.2M	Buy